We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Share News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.55
Bid: 9.30
Ask: 9.80
Change: -0.05 (-0.52%)
Spread: 0.50 (5.376%)
Open: 9.60
High: 9.60
Low: 9.55
Prev. Close: 9.60
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

SUMMARY: London listings with exposure to Silicon Valley Bank

Mon, 13th Mar 2023 12:18

(Alliance News) - The following is a round-up of updates on exposure to Silicon Valley Bank by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

FTSE 250

----------

Syncona Ltd - London-based investor in healthcare companies - Says it has cash and cash equivalents with SVB UK Ltd equating less than 0.4% of its capital base of GBP653.8 million, and 0.2% of its net asset value. Portfolio companies have "range of banking relationships" including SVB and SVB UK, and estimates its indirect exposure across portfolio is around 6% of NAV, "with all but a de minimus amount with SVBUK". Working closely with portfolio companies to support ongoing operations, and engagement with SVBUK and other parties to recovery deposits. Has strong capital base to support portfolio companies if required, awaits guidance from Bank of England over progress and timeline to potentially recover deposits.

----------

IP Group PLC - Oxford, England-based intellectual property commercialisation company - Confirms no direct deposits, credit facilities or other relationships with SVB or SVB UK. Boasts strong balance sheet, with GBP241.5 million in gross cash and deposits as at December 31, and total potential liquidity of over GBP500 million. Working closely with "small number" of portfolio companies that may require short-term liquidity. "Our strong financial position means we are well placed to support our portfolio," firm says.

----------

Auction Technology Group PLC - London-based online auction operator - Says SVB is involved in its senior facilities arrangement with syndicate of six banks. The arrangement consists of a fully-drawn USD150.3 million senior term loan, and a USD49.0 million multi-currency revolving credit facility, which is drawn down by USD24.3 million. SVB represents one sixth of its respective drawn and undrawn facilities. Says liquidity position strong, benefitting from operational cash generation and access to liquidity from other five banks in syndicate. As at Thursday, has USD10.0 million cash at bank, with 5% held on deposit at SVB. "This deposit is held across the group's different US entities. The group uses JP Morgan Chase and HSBC for its main clearing and operational uses," firm says. Expects "no material impact" to current or future liquidity from SVB situation.

----------

Moonpig Group PLC - online greeting card and gifting company - Says SVB is one of ten lenders in banking syndicate which provide its senior debt facilities. Has "significant" liquidity headroom, including utilised and available facilities of GBP242 million, which are committed until December 8 2025. "This excludes the GBP13 million undrawn portion of SVB UK's commitment," firm says. Confirms no cash on deposit with SVB UK and no bank account held with them.

----------

Apax Global Alpha Ltd - Guernsey-based closed-ended investment company - Receives update from Apax Partners, which advises certain private equity funds in which it is a limited partner. Says review is ongoing but exposure to SVB "appears to be limited". Review has not identified any portfolio company with funded debt or revolvers placed with SVB. Small number of portfolio companies have bank accounts at SVB, but the "vast majority of which only hold a very limited amount of cash". No exposure to SVB at the level of Apax Funds.

----------

Future PLC - Bath, England-based magazine publisher - Says cash deposits with SVB were less than 3% of its cash on hand as at Thursday. SVB also provided GBP50 million of its GBP900 million total debt facilities. "Of this GBP50 million, approximately 48% is currently drawn," it says. Has access to "significant" liquidity, with GBP26 million cash on hand as at Friday, and GBP438 million of undrawn committed facilities, excluding SVB's undrawn hold.

----------

HgCapital Trust PLC - London-based investment firm - Says "little to no impact" on the firm from SVB collapse. Says neither Hg, nor any of its managed funds, have related loan or borrowing exposure with SVB. None of its underlying portfolio companies have outstanding borrowings with SVB. "A small number of the underlying portfolio companies have limited deposits with SVB, but no portfolio business is at risk as a result of this."

----------

LARGE SMALL-CAP AND AIM LISTINGS

----------

Team17 Group PLC - Nottingham, England-based video game development company and publisher of educational entertainment apps for children - Says Team17 USA, part of its Games Label division has legacy banking relationship with SVB, but the account is "no longer used for current trading". Says exposure to SVB is less than 1% of cash reserves at present, and "as such is immaterial to the group's liquidity position".

----------

Learning Technologies Group PLC - London-based learning and talent solutions - Says exposure to SVB and SVB UK does not have "material effect" on financial position. As at Friday, had total cash and cash equivalents of GBP110.7 million, of which around GBP11.7 million was on deposit with SVB and SVB UK. Around GBP9.4 million was with SVB, with around GBP2.3 million with SVB UK. Requested withdrawal of deposits, and has received GBP300,000 to date. "The company will continue to pursue any unreturned deposits, including if necessary through the relevant receivership process," LTG says. SVB was also part of its banking syndicate, which comprises HSBC, Bank of Ireland, and Fifth Third Bank. The facilities comprise a drawn USD255.4 million loan - with SVB providing USD53.7 million, and an undrawn revolving credit facility of USD50 million - with SVB's share being USD10.5 million. "SVB's portion of the term loan will continue to be outstanding until it is due to be repaid or SVB is replaced." Says it's unlikely SVB will fund any future drawings on RCF, but the remaining USD39.5 million will be available as normal. SVB was also facility agent for the lending syndicate, and the firm will find a replacement.

----------

THG PLC - Manchester Airport-headquartered e-commerce retail company - Confirms no exposure to SVB in relation to cash or debt facilities.

----------

RWS Holdings PLC - Buckinghamshire, England-based technology-enabled language services provider - Says exposure to SBV "limited", with SVB UK being part of its eight-bank syndicated providing USD220 million revolving credit facility, having committed around 10% of the facility. Around USD26 million is currently drawn down, of which SVB's share is USD2.7 million. Has "small" cash position held within SVB in the US, which it believes with be fully protected under the Federal Deposit Insurance Corporation scheme. SVB UK holds "a portion" of its forward currency contracts, and RWS is working to minimise its "limited" exposure to these contracts. Reiterates outlook from annual general meeting statement, expecting to delivery annual adjusted pretax profit in line with market expectations.

----------

Oxford BioMedica PLC - Oxfordshire, England-based gene and cell therapy group - Says its US facility maintains a checking and deposit account with SVB. Has no accounts with SVB UK. "Oxford Biomedica confirms it has no balance sheet risk exposure to the SVB receivership issue."

----------

Alpha Group International PLC - London-based provider of financial solutions - Says operations and client held funds unaffected by SVB situations. Reaffirms that all client funds are in segregated safeguarding accounts with tier 1 counterparties, comprised of Barclays Bank, Citibank, Goldman Sachs, and Lloyds Bank. "In addition, unlike a bank, Alpha does not use client cash to issue loans, and therefore 100% of client held funds remain in cash at all times," it explains. Says it will monitor potential knock-on effects from SVB on its clients.

----------

BioPharma Credit PLC - Winchester, England-based life sciences debt investment trust - The firm's investment adviser, Pharmakon Advisors, says firm does not hold deposits or other investments in SVB. Has consulted the firm's borrowers, and they report "no significant exposure" to SVB.

----------

OTHER

----------

Dianomi PLC - London-based digital advertising platform - Says on Thursday's close of business, it had total cash balances of around GBP9.6 million, mostly held with JPMorgan and Westpac, but around GBP3.8 million was held with SVB and SVB UK "across a variety of different currency accounts". They held GBP900,000 and GBP2.9 million respectively. Noting developments in the UK and US, now expects these deposits to be fully protected.

----------

Trustpilot Group PLC - Copenhagen-based online consumer reviews platform - Says SVB UK was principal banking partner. Its immediately accessible cash is USD24 million, made up of USD19 million cash on deposit with another bank, USD4.5 million guaranteed by the US Federal Reserve after Sunday's announcement, and amounts due to be returned under guaranteed deposit insurance schemes in UK. "The board is confident in Trustpilot's' liquidity position and resilience. Meanwhile, we have put in place measures to proactively manage our cash position during this period of uncertainty, and wider unpredictability in the current macroeconomic environment," Trustpilot says.

----------

Polarean Imaging PLC - London-based medical imaging technology company - Says at the end of February it had USD13.9 million in cash, with USD12.4 million held at SVB. USD9.8 million of the amount held by SVB is held in money market mutual fund accounts operated by other financial institutions. Also holds USD1.0 million in SVB checking account, and GBP1.2 million in SVB sterling checking account. Notes FDIC guarantees USD250,000 of deposits in US. Believes USD9.8m MMFA shares are not considered deposits of SVB, and therefore are not part of the receivership estate. "However, Polarean may not have immediate access to these funds until the FDIC establishes procedures for access," the firm says. Says USD1.5 million held by Wells Fargo will fund its working capital needs until the end of April this year.

----------

Diaceutics PLC - Belfast-based testing laboratories company - Says as at Thursday, it holds GBP19.8 million in cash and cash equivalents with SVB UK. Is now confident the funds will be fully recovered, following HSBC acquisition. Earlier, the firm had ordered the suspension of its shares on AIM, due to uncertainty about its ability to service working capital requirements. It now removes suspension. Continues trying to get access to the GBP2.2 million held on deposit with SVB in the US. Following the announcement from the Federal Reserve about restoring access to deposits, it expects to be able to access the funds in the "near term".

----------

Naked Wines PLC - Norwich-based online wine seller - Says holds cash in variety of SVB accounts in US and UK. SVB is also administrative agent and issuing lender for its USD60 million asset-backed credit facility. On Friday, had gross cash on hand of GBP32 million, GBP14 million of which was held in cash sweep account with SVB acting as custodian for third party money market funds. Believes it is entitled to return of these funds in full, after completing any procedures required by FDIC. Is uncertain of the time frame in which it will gain full access to these funds. Says day-to-day operations unaffected, and doesn't expect to incur any loss as a result. Says GBP17 million available in immediately accessible cash.

----------

Access Intelligence PLC - London-based software-as-a-service products provider - Says SVB it has deposits with less than GBP400,000 held across a number of SVB accounts in the UK and US. It expects most of the funds, if not all, to be protected by the UK Financial Services Compensation Scheme and the US FDIC. "However the exact timing of when these funds might be available to the company still remains uncertain," firm says. Notes SVB is not a banking partner of the company in the Asia-Pacific region.

----------

Glantus Holdings PLC - Dublin-based data platform for accounts payable and shared services - Says it SVB is used for US operations. "Proactively managing" situation, and does not expected significant operational difficulties. Says maximum exposure will "only slightly" exceed the USD250,000 amount insured by FDIC. "Consequently, the board is confident that the current situation regarding SVB will not have a material impact on Glantus."

----------

Medica Group PLC - Hastings, England-based company which provides services such as X-ray and MRI scan analysis to hospitals - Says SVB UK is part of three-bank lending consortium, alongside NatWest and Lloyds. Says around GBP10 million of the GBP30 million revolving credit facility was being used at the end of December. "The RCF facility is not required for day-to-day activity, is not forecast to be further drawn and Medica intends to pay this facility down out of trading cashflows within the next 12-18 months," firm says. Has no cash on deposit nor conducts any day-to-day commercial banking with any SVB entity.

----------

eEnergy Group PLC - London-based energy efficiency-as-a-service provider - Says it has no material operating cash exposure to SVB, but maintains a number of bank accounts with SVB UK, "primarily used in relation to collections from clients on behalf of project funders". Its primary relationship with SVB concerns currency hedging, and a fully drawn GBP5 million revolving credit facility. "The board does not expect any material impact to its business, adjusted earnings or cash position."

----------

Venture Life Group PLC - Berkshire, England-based self-care product manufacturer and distributor - Says SVB participates in its GBP30 million revolving credit facility, which is primarily co-ordinated and managed by firm's main relationship bank, Santander UK. SVB provides 50% of the funds drawn under the facility. The RCF has an option for Santander to take of SVB's portion, or for another lender to participate in the RCF. "The group has commenced discussions with Santander in relation to Santander doing this, and those initial discussions have been positive," VLG says. Santander and firm will accelerate plans to refinance the RCF, given that it expires next June. Says firm and subsidiaries have no deposits with SVB in UK or US, meaning no funds at risk.

----------

Checkit PLC - Cambridge-based workflow management software provider - Says exposure to SVB less than GBP100,000. Says balance sheet strong, with net cash of GBP15.6 million at January 31.

----------

PCI-PAL PLC - Global cloud provider of secure payment solutions for business communications - As of Thursday, had GBP3.2 million of cash in accounts with SVB, split between the US and UK. Notes US and UK developments ensuring safety of its deposits. Says trading in the second so far has been in line with the board's expectations.

----------

Yourgene Health PLC - Manchester-based molecular diagnostics - Says it has GBP3 million in outstanding borrowings under a loan agreement with SVB UK. Holds around GBP20,000 on deposit with SVB UK in accounts which are only used to pay loan instalments or associated interest. Says SVB US exposure is for day-to-day trading purposes for small US commercial team, and "handful" of company credit cards. Says the "modest" level of funds held in US SVB account were transferred to other banks last week. Believes remaining SVB deposits are protected by relevant insurance schemes in UK and US.

----------

musicMagpie PLC - Stockport, England-based used-technology reseller - Says it had a loan arrangement with SVB, but this ended when it entered the three-year GBP30 million revolving credit facility with HSBC and NatWest last July. Its US trading brand, decluttr, uses SVB for day-to-day activities. Says SVB closure in US is unlikely to impact business because decluttr can use alternative banking relationships. "The group had already been in discussions to move its US transactional banking relationship away from SVB," the firm says.

----------

Windward Ltd - Liverpool, England-based maritime predictive intelligence company - Says exposure "minimal", and expects funds to be protected by US and UK schemes. Says exposure amount is less than 0.5% of its cash position, which was USD22.2 million at December 31.

----------

Eagle Eye Solutions Group PLC - London-based marketing solutions provider - Says it has a GBP5.0 million loan facility with SVB UK, which is draw down by GBP2.0 million. On Friday, had total cash of around GBP7.8 million. Notes some funds deposited with SVB in US, but expects these to be protected and available from today. Has no cash deposits with SVB UK.

----------

GetBusy PLC - Cambridge, England-based document management and productivity software provider - Says its previous loan facility with SVB was cancelled last month, and replaced with a GBP2 million facility with DJZ Investments Pty Ltd. "Following this executed change, the group has no exposure to SVB for any loan facilities." Says no exposure to uninsured deposits with SVB, given the announcements from the Treasure, Federal Reserve and FDIC on Sunday.

----------

The following firms cited no banking relationship with/no exposure to SVB:

Argentex Group PLC

Avacta Group PLC

Cornerstone FS PLC

CyanConnode Holdings PLC

Equals Group PLC

Evgen Pharma PLC

Fiinu PLC

GENinCode PLC

Instem PLC

LungLife AI Inc

Mercia Asset Management PLC

Renalytix PLC

Roquefort Therapeutics PLC

Scancell Holdings PLC

Science Group PLC

Seeing Machines Ltd

Spectral MD Holdings Ltd

Tern PLC

Verici Dx PLC

----------

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
26 Mar 2024 14:00

Scancell doses first patient in melanoma-focused trials

(Alliance News) - Scancell Holdings PLC announced on Tuesday that the first patient of a new trial cohort has been dosed with its iSCIB1+ therapeutic.

Read more
5 Feb 2024 14:09

TRADING UPDATES: Alliance Pharma appoints chair; FireAngel sales down

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
30 Jan 2024 13:56

Scancell interim loss narrows amid finance gain on derivative

(Alliance News) - Scancell Holdings PLC on Tuesday reported a narrowed loss as it gained on the revaluation of derivative liability.

Read more
17 Jan 2024 14:26

IN BRIEF: Scancell approved by MHRA to add new cohort to Scope trial

Scancell Holdings PLC - Oxford, England-based developer of immunotherapies for treatment of cancer and infectious disease said - Receives approval from UK's Medicines & Healthcare products Regulatory agency to add a third cohort to the Scope trial. Says the cohort will consist of 43 melanoma patients who will receive iSCIB1+ with doublet therapy, consisting of ipilimumab, under the brand name Yervoy, plus nivolumab, under the name Opdivo. "Exceptional" results from the first 13 patients receiving SCIB1 in the ongoing Scope trial, with an objective response rate of 85%, indicate a high probability of success in this cohort, which is expected to complete in the second quarter of 2024. Meanwhile, recruitment into the iSCIB1+ cohort is expected to be complete by the end of the second quarter as well, with early data expected in the third quarter of 2024.

Read more
19 Dec 2023 13:35

Scancell raises GBP12 million in total from fundraise

(Alliance News) - Scancell Holdings PLC on Tuesday said it has raised GBP11.9 million in total, from an open offer, placing, and subscription of shares.

Read more
1 Dec 2023 09:54

IN BRIEF: Scancell raises GBP10.7 million in upsized share sale

Scancell Holdings PLC - Oxford, England-based developer of immunotherapies for treatment of cancer and infectious disease - Raises GBP10.7 million from the placing and subscription of 97.0 million new shares at 11 pence each. The placing is run by Stifel Nicolaus Europe Ltd and WG Partners LLP. Scancell also plans an open offer of shares at the same price to raise up to another GBP2.0 million. Scancell says the placing was oversubscribed and upsized as a result. After the London market close on Thursday, Scancell had announced plans to raise just GBP6 million in the placing. It says the raise was led by "new institutional and life science specialist investors".

Read more
30 Nov 2023 21:10

EARNINGS AND TRADING: Dispensa and SkinBioTherapeutics losses widen

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
28 Nov 2023 14:57

TRADING UPDATES: Scancell trial progresses; OptiBiotix inks new deal

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
22 Nov 2023 15:53

UK shareholder meetings calendar - next 7 days

Thursday 23 November 
abrdn UK Smaller Companies Growth Trust PLCAGM
Avation PLCAGM
Bradda Head Lithium LtdAGM
DX Group PLCAGM
Europa Oil & Gas Holdings PLCAGM
Fiske PLCAGM
JPMorgan UK Smaller Cos Investment Trust PLCAGM
Hotel Chocolat Group PLCAGM
Pacific Horizon Investment Trust PLCAGM
Pan African Resources PLCAGM
PZ Cussons PLCAGM
Rosslyn Data Technologies PLCAGM
Friday 24 November 
Base Resources LtdAGM
Cloudbreak Discovery PLCAGM
Esken LtdEGM re Esken Renewables disposal
Neometals LtdAGM
Sovereign Metals LtdAGM
Sylvania Platinum LtdAGM
Monday 27 November 
Chelverton Growth Trust PLCGM re voluntary liquidation
European Smaller Cos Trust PLCAGM
JPMorgan Global Emerging Markets Income Trust PLCAGM
Quadrise PLCAGM
Tribal Group PLCGM re cash offer by Tiger Bidco 1 Ltd
Tuesday 28 November 
Bluefield Solar Income Fund LtdAGM
London Finance & Investment Group PLCAGM
Nanoco Group PLCAGM
Oakley Capital Investments LtdAGM
Wednesday 29 November 
Artemis Resources LtdAGM
Aura Energy LtdAGM
Contango Holdings PLCAGM
CVS Group PLCAGM
Fidelity Asian Values PLCAGM
Ikigai Ventures LtdAGM
Panthera Resources PLCAGM
Reconstruction Capital II LtdAGM
Renishaw PLCAGM
RiverFort Global Opportunities PLCAGM
Sabien Technology Group PLCAGM
Scancell Holdings PLCAGM
Seeing Machines LtdAGM
SLF Realisation Fund LtdAGM
Target Healthcare REIT PLCAGM
Thor Energy PLCAGM
Transense Technologies PLCAGM
Vast Resources PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
10 Nov 2023 11:14

IN BRIEF: Scancell shares up as presents "trailblazing" trial data

Scancell Holdings PLC - Nottingham, England-based cancer immunotherapies developer - Presents data from first stage of Phase 2 Scope trial at 20th International Congress of the Society for Melanoma Research on Thursday. Trial investigates Scancell's SCIB1 vaccination combined with checkpoint inhibitors in advanced melanoma. Company reported mid-September that SCIB1 combined with CPIs showed an 82% objective response rate. Scope trial is currently in its second stage. Scancell says on Friday that in Cohort 1 nine responses were achieved earlier than expected, and probability of second-stage success is around 90% based on current data.

Read more
31 Oct 2023 14:45

EARNINGS: Frontier IP chair to step down; "busy" Rosslyn narrows loss

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
20 Oct 2023 09:00

IN BRIEF: Scancell says needs more time to publish annual results

Scancell Holdings PLC - Nottingham, England-based cancer immunotherapies developer - Says auditor request additional time to complete standard audit of its results of financial year 2023 that ended on April 30. Cites unforeseen circumstances impacting the audit engagement team. Says audit is substantially complete without any material audit issues.

Read more
17 Oct 2023 15:43

UK earnings, trading statements calendar - next 7 days

Wednesday 18 October 
888 Holdings PLCTrading Statement
Antofagasta PLCTrading Statement
BHP Group LtdTrading Statement
Cirata PLCTrading Statement
Hochschild Mining PLCTrading Statement
Liontrust Asset Management PLCTrading Statement
Quilter PLCTrading Statement
Segro PLCTrading Statement
Sosandar PLCTrading Statement
Whitbread PLCHalf Year Results
Thursday 19 October 
AJ Bell PLCTrading Statement
Centamin PLCQ3 Results
Deliveroo PLCTrading Statement
Dunelm Group PLCTrading Statement
GB Group PLCTrading Statement
Gear4Music PLCHalf Year Results
Hargreaves Lansdown PLCTrading Statement
London Stock Exchange Group PLCTrading Statement
Man Group PLCTrading Statement
Mondi PLCTrading Statement
PensionBee Group PLCTrading Statement
Rathbones Group PLCTrading Statement
Relx PLCTrading Statement
Rentokil Initial PLCQ3 Results
Sabre Insurance Group PLCTrading Statement
Schroders PLCTrading Statement
St James's Place PLCTrading Statement
Friday 20 October 
Foxtons Group PLCTrading Statement
InterContinental Hotels Group PLCTrading Statement
Record PLCTrading Statement
Monday 23 October 
Shanta Gold LtdTrading Statement
South32 LtdTrading Statement
Tuesday 24 October 
Angling Direct PLCHalf Year Results
Anglo American PLCTrading Statement
Barclays PLCQ3 Results
Bunzl PLCTrading Statement
FD Technologies PLCHalf Year Results
Gattaca PLCFull Year Results
Petra Diamonds LtdQ1 Results
Scancell Holdings PLCFull Year Results
Softcat PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
WAG Payment Solutions PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
22 Sep 2023 13:05

IN BRIEF: Oxford Technology 2 VCT asset value hurt by AIM share falls

Oxford Technology 2 VCT PLC - venture capital trust investing in quoted and unquoted technology companies - Net asset value of OT1 shares falls by 16% to 37.9 pence on August 31 from 45.3p on February 28. Similarly, NAV of OT2 shares falls to 20.5p from 25.1p, of OT3 shares to 23.6p from 33.7p, and of OT4 shares to 25.4p from 29.7p. No dividends are paid during the half year, nor are any shares bought back.

Read more
19 Sep 2023 14:32

Scancell celebrates "positive" clinical trial data for cancer vaccine

(Alliance News) - Scancell Holdings PLC shares surged on Tuesday after the company announced positive results from the phase 2 clinical trial of its SCIB1 treatment for advanced melanoma.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.